Overview

Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)

Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that carvedilol, at less then therapeutic doses for cardiac effect, will reduce symptoms of Post Traumatic Stress Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Columbia Northwest Pharmaceuticals
Treatments:
Carvedilol